DCGI asks SLAs to withdraw 13 brands of ‘AZ’ with different ingredients

This news is not related with the Human Placental Extract, but as its an issue related with Indian Pharma companies, we are placing this news here. For the complete details you've to visit the link provided in this post.

Following the instruction from the Drug Controller General of India (DCGI) to the State Licensing Authorities to withdraw permission to the drugs having same brand name of ‘AZ’ but with different ingredients, as many as 13 other formulations under this category have been banned in different places so far.

Read more at: Pharmabiz.com Courtesy & Copyright:PHARMABIZ.COM Joseph Alexander, New DelhiFriday, March 11, 2011, 08:00 Hrs  [IST]